ArticlesVC
Galvanize Therapeutics Raises $130M From Healthquest Capital
Galvanize Therapeutics raises $130M Series A+ led by HealthQuest Capital.
By Traded Media1 min read
Galvanize Therapeutics raises $130M Series A+ led by HealthQuest Capital.
Galvanize Therapeutics develops commercial-stage company advancing pulsed electric field (PEF) ablation technologies.
Galvanize Therapeutics will use the funds to to accelerate commercial growth and advance PEF innovation.
Galvanize Therapeutics is based in Redwood City.
The company is led by CEO Jonathan Waldstreicher.
| Company | Galvanize Therapeutics |
|---|---|
| Round | Series A+ |
| Amount | $130M |
| Lead Investor | HealthQuest Capital |
| Founders | Jonathan Waldstreicher |
| Sectors | oncology and chronic disease |
ABOUT THIS STORY
- Desk
- Articles
- Filed
- Nov 18, 2026
- By
- Traded Media